ACT Genomics Is At A Fresh Turning Point Under COVID-19 In 2020 US BIO Digital

2020-06-05

ACT Genomics is chosen by Taipei City Government as representative to join US BIO Digital, the world’s largest biotechnology exhibition, with OBI Pharma, belxbiopharma, NatureWise Biotech & Medicals, Far East Bio-tec and AcroMass Technology. This 24 hour one-on-one partnering fosters the new biotech economy post COVID-19 with more flexibility. After successful mask diplomacy, Taiwan's biotech industry aims to bring high-end R&D capability on the international stage and seeks for forward-looking partners to create new opportunities hand in hand.

Image title